On the other hand, ACSL4-driven enrichment of PUFA-containing phospholipids establishes the biochemical foundation for ferroptosis, sensitizing tumor cells to sorafenib and CD8<sup>+</sup> T cell-mediated oxidative killing. Here, ACSL4 is linked to neoplasm.